{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T02:19:06Z","timestamp":1773368346461,"version":"3.50.1"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2020.00354","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T08:20:52Z","timestamp":1587025252000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Circulating MicroRNAs as Diagnostic Biomarkers for Motor Neuron Disease"],"prefix":"10.3389","volume":"14","author":[{"given":"Lin","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/bpa.12370","article-title":"Alpha-synuclein as a biomarker for Parkinson\u2019s disease.","volume":"26","author":"Atik","year":"2016","journal-title":"Brain Pathol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"8217","DOI":"10.1523\/JNEUROSCI.1159-19.2019","article-title":"Phenotypic suppression of ALS\/FTD-associated neurodegeneration highlights mechanisms of dysfunction.","volume":"39","author":"Bartoletti","year":"2019","journal-title":"J. Neurosci."},{"key":"B3","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s12017-016-8396-8","article-title":"Identification of miRNAs as potential biomarkers in cerebrospinal fluid from amyotrophic lateral sclerosis patients.","volume":"18","author":"Benigni","year":"2016","journal-title":"Neuromol. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-1-4939-7601-0_2","article-title":"Target mRNA-driven biogenesis of cognate MicroRNAs in vitro.","volume":"1733","author":"Bose","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094839","article-title":"Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer\u2019s and Parkinson\u2019s diseases correlate with disease status and features of pathology.","volume":"9","author":"Burgos","year":"2014","journal-title":"PLoS One"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2016.47","article-title":"Altered levels of MicroRNA-9, -206, and -132 in spinal muscular atrophy and their response to antisense oligonucleotide therapy.","volume":"5","author":"Catapano","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0742-x","article-title":"Down-regulation of miR-9\u2217 in the peripheral leukocytes of Huntington\u2019s disease patients.","volume":"12","author":"Chang","year":"2017","journal-title":"Orphanet. J. Rare Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s12640-009-9129-7","article-title":"The kynurenine pathway and inflammation in amyotrophic lateral sclerosis.","volume":"18","author":"Chen","year":"2010","journal-title":"Neurotox Res."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2016.00069","article-title":"Aberration of miRNAs expression in leukocytes from sporadic amyotrophic lateral sclerosis.","volume":"9","author":"Chen","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10048-014-0420-2","article-title":"miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients.","volume":"15","author":"De Felice","year":"2014","journal-title":"Neurogenetics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ncrna.2018.12.001","article-title":"Dysregulation of microRNA metabolism in motor neuron diseases: novel biomarkers and potential therapeutics.","volume":"4","author":"De Paola","year":"2019","journal-title":"Noncoding RNA Res."},{"key":"B12","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2188\/jea.JE20140059","article-title":"Prevalence and incidence of amyotrophic lateral sclerosis in Japan.","volume":"24","author":"Doi","year":"2014","journal-title":"J. Epidemiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/nrneurol.2015.77","article-title":"Spinal muscular atrophy\u2013recent therapeutic advances for an old challenge.","volume":"11","author":"Faravelli","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"B14","doi-asserted-by":"crossref","first-page":"e2615","DOI":"10.1016\/j.neurobiolaging.2015.06.003","article-title":"Serum microRNAs in sporadic amyotrophic lateral sclerosis.","volume":"36","author":"Freischmidt","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20174152","article-title":"Diagnostic and prognostic role of blood and cerebrospinal fluid and blood neurofilaments in amyotrophic lateral sclerosis: a review of the literature.","volume":"20","author":"Gagliardi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075091","article-title":"Increased neurofilament light chain blood levels in neurodegenerative neurological diseases.","volume":"8","author":"Gaiottino","year":"2013","journal-title":"PLoS One"},{"key":"B17","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00401-011-0797-z","article-title":"Motor neuron disease clinically limited to the lower motor neuron is a diffuse TDP-43 proteinopathy.","volume":"121","author":"Geser","year":"2011","journal-title":"Acta Neuropathol."},{"key":"B18","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2174\/1871527315666160815164808","article-title":"Dysregulation of RNA mediated gene expression in motor neuron diseases.","volume":"15","author":"Goncalves","year":"2016","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"B19","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1007\/s10072-017-3086-3","article-title":"Secretases-related miRNAs in Alzheimer\u2019s disease: new approach for biomarker discovery.","volume":"38","author":"Hajjari","year":"2017","journal-title":"Neurol. Sci."},{"key":"B20","doi-asserted-by":"crossref","first-page":"13111","DOI":"10.1073\/pnas.1006151107","article-title":"miRNA malfunction causes spinal motor neuron disease.","volume":"107","author":"Haramati","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B21","doi-asserted-by":"crossref","first-page":"478","DOI":"10.4161\/cib.3.5.12693","article-title":"Secretory microRNAs as a versatile communication tool.","volume":"3","author":"Iguchi","year":"2010","journal-title":"Commun. Integr. Biol."},{"key":"B22","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s10072-017-3071-x","article-title":"Circulating pro-angiogenic and anti-angiogenic microRNA expressions in patients with acute ischemic stroke and their association with disease severity.","volume":"38","author":"Jin","year":"2017","journal-title":"Neurol. Sci."},{"key":"B23","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.03.048","article-title":"MicroRNA expression profiles of neuron-derived extracellular vesicles in plasma from patients with amyotrophic lateral sclerosis.","volume":"708","author":"Katsu","year":"2019","journal-title":"Neurosci. Lett."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2014.00015","article-title":"The role of miRNA in motor neuron disease.","volume":"8","author":"Kye","year":"2014","journal-title":"Front. Cell Neurosci."},{"key":"B25","doi-asserted-by":"crossref","first-page":"6318","DOI":"10.1093\/hmg\/ddu350","article-title":"SMN regulates axonal local translation via miR-183\/mTOR pathway.","volume":"23","author":"Kye","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2019.134523","article-title":"C9ORF72 protein function and immune dysregulation in amyotrophic lateral sclerosis.","volume":"713","author":"Lai","year":"2019","journal-title":"Neurosci. Lett."},{"key":"B27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene.","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s10072-017-2841-9","article-title":"Plasma levels of miR-137 and miR-124 are associated with Parkinson\u2019s disease but not with Parkinson\u2019s disease with depression.","volume":"38","author":"Li","year":"2017","journal-title":"Neurol. Sci."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2018.00288","article-title":"Dysregulation of MicroRNAs and target genes networks in peripheral blood of patients with sporadic amyotrophic lateral sclerosis.","volume":"11","author":"Liguori","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10072-018-3633-6","article-title":"Analysis of clinical and electrophysiological characteristics of 150 patients with amyotrophic lateral sclerosis in China.","volume":"40","author":"Liu","year":"2019","journal-title":"Neurol. Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10072-018-3653-2","article-title":"Efficacy and safety of edaravone in treatment of amyotrophic lateral sclerosis-a systematic review and meta-analysis.","volume":"40","author":"Luo","year":"2019","journal-title":"Neurol. Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/jcmm.13450","article-title":"miRNA in spinal muscular atrophy pathogenesis and therapy.","volume":"22","author":"Magri","year":"2018","journal-title":"J. Cell Mol. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.neurobiolaging.2017.12.020","article-title":"Genome-wide circulating microRNA expression profiling reveals potential biomarkers for amyotrophic lateral sclerosis.","volume":"64","author":"Matamala","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"B34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/547153a","article-title":"Stop Alzheimer\u2019s before it starts.","volume":"547","author":"McDade","year":"2017","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ygeno.2008.07.001","article-title":"Applications of next-generation sequencing technologies in functional genomics.","volume":"92","author":"Morozova","year":"2008","journal-title":"Genomics"},{"key":"B36","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/1573406411666151030112140","article-title":"miRNAs as circulating biomarkers for Alzheimer\u2019s disease and Parkinson\u2019s disease.","volume":"12","author":"Mushtaq","year":"2016","journal-title":"Med. Chem."},{"key":"B37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"B38","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.bbrc.2010.07.008","article-title":"Adipocyte-derived microvesicles contain RNA that is transported into macrophages and might be secreted into blood circulation.","volume":"398","author":"Ogawa","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B39","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/cyto.a.20886","article-title":"Flow cytometric analysis of circulating microparticles in plasma.","volume":"77","author":"Orozco","year":"2010","journal-title":"Cytometry A"},{"key":"B40","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jns.2017.07.008","article-title":"Micro-RNAs in ALS muscle: differences in gender, age at onset and disease duration.","volume":"380","author":"Pegoraro","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00532","article-title":"Motor neuron susceptibility in ALS\/FTD.","volume":"13","author":"Ragagnin","year":"2019","journal-title":"Front. Neurosci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/mus.26106","article-title":"Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis.","volume":"58","author":"Raheja","year":"2018","journal-title":"Muscle Nerve"},{"key":"B43","doi-asserted-by":"crossref","DOI":"10.3390\/cells7110219","article-title":"MicroRNAs as biomarkers in amyotrophic lateral sclerosis.","volume":"7","author":"Ricci","year":"2018","journal-title":"Cells"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089237","article-title":"Assessment of RT-qPCR normalization strategies for accurate quantification of extracellular microRNAs in murine serum.","volume":"9","author":"Roberts","year":"2014","journal-title":"PLoS One"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2019.116540","article-title":"Factors contributing to delays in the diagnosis of motor neuron disease - A south Australian study.","volume":"407","author":"Sharrad","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1093\/hmg\/ddx230","article-title":"Astrocyte-produced miR-146a as a mediator of motor neuron loss in spinal muscular atrophy.","volume":"26","author":"Sison","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-018-0220-y","article-title":"A non-invasive liquid biopsy screening of urine-derived exosomes for miRNAs as biomarkers in endometrial cancer patients.","volume":"20","author":"Srivastava","year":"2018","journal-title":"AAPS J."},{"key":"B48","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ncl.2015.07.006","article-title":"Patterns of weakness, classification of motor neuron disease, and clinical diagnosis of sporadic amyotrophic lateral sclerosis.","volume":"33","author":"Statland","year":"2015","journal-title":"Neurol. Clin."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-015-0161-7","article-title":"Identification of plasma microRNAs as a biomarker of sporadic amyotrophic lateral sclerosis.","volume":"8","author":"Takahashi","year":"2015","journal-title":"Mol. Brain"},{"key":"B50","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/B978-0-12-802973-2.00013-6","article-title":"The epidemiology of amyotrophic lateral sclerosis.","volume":"138","author":"Talbott","year":"2016","journal-title":"Handb. Clin. Neurol."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.01013","article-title":"Kynurenine pathway metabolites as biomarkers for amyotrophic lateral sclerosis.","volume":"13","author":"Tan","year":"2019","journal-title":"Front. Neurosci."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05049-z","article-title":"Abnormal RNA stability in amyotrophic lateral sclerosis.","volume":"9","author":"Tank","year":"2018","journal-title":"Nat. Commun."},{"key":"B53","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature20413","article-title":"Decoding ALS: from genes to mechanism.","volume":"539","author":"Taylor","year":"2016","journal-title":"Nature"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-016-0658-1","article-title":"ALS: recent developments from genetics studies.","volume":"16","author":"Therrien","year":"2016","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1007\/s11033-019-04614-z","article-title":"Serum miR-30c-5p is a potential biomarker for multiple system atrophy.","volume":"46","author":"Vallelunga","year":"2019","journal-title":"Mol. Biol. Rep."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128560","article-title":"Expression of muscle-specific MiRNA 206 in the progression of disease in a murine SMA model.","volume":"10","author":"Valsecchi","year":"2015","journal-title":"PLoS One"},{"key":"B57","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.neulet.2016.07.059","article-title":"Silencing strategies for therapy of SOD1-mediated ALS.","volume":"636","author":"Van Zundert","year":"2017","journal-title":"Neurosci. Lett."},{"key":"B58","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2016-315469","article-title":"ALS genetic epidemiology \u2018How simplex is the genetic epidemiology of ALS?\u2019.","volume":"88","author":"Veldink","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B59","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/WCO.0000000000000744","article-title":"Neurochemical biomarkers in amyotrophic lateral sclerosis.","volume":"32","author":"Verde","year":"2019","journal-title":"Curr. Opin. Neurol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/ncb2210","article-title":"MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins.","volume":"13","author":"Vickers","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.neurobiolaging.2017.03.027","article-title":"Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS).","volume":"55","author":"Waller","year":"","journal-title":"Neurobiol. Aging"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00731","article-title":"Small RNA sequencing of sporadic amyotrophic lateral sclerosis cerebrospinal fluid reveals differentially expressed miRNAs related to neural and glial activity.","volume":"11","author":"Waller","year":"","journal-title":"Front. Neurosci."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041561","article-title":"Comparing the MicroRNA spectrum between serum and plasma.","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"B64","doi-asserted-by":"publisher","first-page":"7248","DOI":"10.1093\/nar\/gkq601","article-title":"Export of microRNAs and microRNA-protective protein by mammalian cells.","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S1474-4422(18)30089-9","article-title":"Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model.","volume":"17","author":"Westeneng","year":"2018","journal-title":"Lancet Neurol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.3892\/etm.2019.7855","article-title":"miR-133b is a potential diagnostic biomarker for Alzheimer\u2019s disease and has a neuroprotective role.","volume":"18","author":"Yang","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e1748","DOI":"10.1212\/WNL.0000000000008439","article-title":"TDP-43 levels in the brain tissue of ALS cases with and without C9ORF72 or ATXN2 gene expansions.","volume":"93","author":"Yang","year":"2019","journal-title":"Neurology"},{"key":"B68","doi-asserted-by":"crossref","DOI":"10.1186\/s13041-019-0448-1","article-title":"Blood-based molecular biomarkers for Alzheimer\u2019s disease.","volume":"12","author":"Zetterberg","year":"2019","journal-title":"Mol. Brain"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2020.00354\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T08:20:57Z","timestamp":1587025257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2020.00354\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,16]]},"references-count":68,"alternative-id":["10.3389\/fnins.2020.00354"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2020.00354","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,16]]},"article-number":"354"}}